These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 28740585)

  • 21. Hypogonadism with Normal Serum Testosterone.
    Borovickova I; Adelson N; Viswanath A; Gama R
    Clin Chem; 2017 Aug; 63(8):1326-1329. PubMed ID: 28751320
    [No Abstract]   [Full Text] [Related]  

  • 22. The Effect of Testosterone on Cardiovascular Biomarkers in the Testosterone Trials.
    Mohler ER; Ellenberg SS; Lewis CE; Wenger NK; Budoff MJ; Lewis MR; Barrett-Connor E; Swerdloff RS; Stephens-Shields A; Bhasin S; Cauley JA; Crandall JP; Cunningham GR; Ensrud KE; Gill TM; Matsumoto AM; Molitch ME; Pahor M; Preston PE; Hou X; Cifelli D; Snyder PJ
    J Clin Endocrinol Metab; 2018 Feb; 103(2):681-688. PubMed ID: 29253154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lessons From the Testosterone Trials.
    Snyder PJ; Bhasin S; Cunningham GR; Matsumoto AM; Stephens-Shields AJ; Cauley JA; Gill TM; Barrett-Connor E; Swerdloff RS; Wang C; Ensrud KE; Lewis CE; Farrar JT; Cella D; Rosen RC; Pahor M; Crandall JP; Molitch ME; Resnick SM; Budoff M; Mohler ER; Wenger NK; Cohen HJ; Schrier S; Keaveny TM; Kopperdahl D; Lee D; Cifelli D; Ellenberg SS
    Endocr Rev; 2018 Jun; 39(3):369-386. PubMed ID: 29522088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacoepidemiology of testosterone: Curbing off-label prescribing.
    Handelsman DJ
    Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1248-1255. PubMed ID: 28833745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Testosterone treatment and cardiovascular events in prescription database studies.
    Shores MM
    Asian J Androl; 2018; 20(2):138-144. PubMed ID: 28816202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex hormones and the risk of atrial fibrillation: The Multi-Ethnic Study of Atherosclerosis (MESA).
    O'Neal WT; Nazarian S; Alonso A; Heckbert SR; Vaccarino V; Soliman EZ
    Endocrine; 2017 Oct; 58(1):91-96. PubMed ID: 28786078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trials of testosterone replacement reporting cardiovascular adverse events.
    Gagliano-Jucá T; Basaria S
    Asian J Androl; 2018; 20(2):131-137. PubMed ID: 28782738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Case Study: Unfavorable But Transient Physiological Changes During Contest Preparation in a Drug-Free Male Bodybuilder.
    Pardue A; Trexler ET; Sprod LK
    Int J Sport Nutr Exerc Metab; 2017 Dec; 27(6):550-559. PubMed ID: 28770669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testosterone Replacement in a Man with Intermediate-risk Prostate Cancer.
    Morales A
    Eur Urol Focus; 2017 Oct; 3(4-5):319-320. PubMed ID: 28753836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in the treatment of erectile dysfunction.
    Mobley DF; Khera M; Baum N
    Postgrad Med J; 2017 Nov; 93(1105):679-685. PubMed ID: 28751439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testosterone and Aggression: More Than Just Biology?
    Coccaro EF
    Biol Psychiatry; 2017 Aug; 82(4):234. PubMed ID: 28748784
    [No Abstract]   [Full Text] [Related]  

  • 32. Adverse effects of androgen deprivation therapy in patients with prostate cancer: focus on metabolic complications.
    Tzortzis V; Samarinas M; Zachos I; Oeconomou A; Pisters LL; Bargiota A
    Hormones (Athens); 2017 Apr; 16(2):115-123. PubMed ID: 28742500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular Pathways of Testosterone: Clinical Implications.
    Lorigo M; Mariana M; Oliveira N; Lemos MC; Cairrao E
    J Cardiovasc Transl Res; 2020 Feb; 13(1):55-72. PubMed ID: 31820333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum testosterone levels in male hypogonadism: Why and when to check-A review.
    Livingston M; Kalansooriya A; Hartland AJ; Ramachandran S; Heald A
    Int J Clin Pract; 2017 Nov; 71(11):. PubMed ID: 28980739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Testosterone Replacement Therapy and the Incidence of a Composite of Postoperative In-hospital Mortality and Cardiovascular Events in Men Undergoing Noncardiac Surgery.
    Argalious MY; You J; Mao G; Ramos D; Khanna S; Maheshwari K; Trombetta C
    Anesthesiology; 2017 Sep; 127(3):457-465. PubMed ID: 28816783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of admission testosterone level with ST-segment resolution in male patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Separham A; Ghaffari S; Sohrabi B; Aslanabadi N; Hadavi Bavil M; Lotfollahi H
    Basic Clin Androl; 2017; 27():14. PubMed ID: 28770092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Testosterone deficiency and dementia].
    Dimopoulou C; Stalla GK
    Dtsch Med Wochenschr; 2017 Aug; 142(15):1102-1105. PubMed ID: 28763818
    [No Abstract]   [Full Text] [Related]  

  • 38. Testosterone replacement therapy and cardiovascular risk.
    Gagliano-Jucá T; Basaria S
    Nat Rev Cardiol; 2019 Sep; 16(9):555-574. PubMed ID: 31123340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Testosterone, myocardial function, and mortality.
    Bianchi VE
    Heart Fail Rev; 2018 Sep; 23(5):773-788. PubMed ID: 29978359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Testosterone replacement therapy: For whom, when and how?
    Tsametis CP; Isidori AM
    Metabolism; 2018 Sep; 86():69-78. PubMed ID: 29530796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.